The purpose of this study was to evaluate the effectiveness of the MOVE! Weight Management Program for Veterans (MOVE!) in achieving weight loss in veterans who attended the multidisciplinary weight management program in the VA Greater Los Angeles Healthcare System.
From April 1, 2006, to December 31, 2009, 382 veterans enrolled in the MOVE! program; 377 veterans attended at least 3 group sessions and were included in this study. All veterans were encouraged to complete 8 weekly group sessions on nutrition, lifestyle changes, and behavior modification in a group setting led by a multidisciplinary team. After completing the session, veterans had the option of continuing with a support group that meets monthly. The change in weight from 1 year pre-enrollment in MOVE! to 1, 2, and 3 years postenrollment was analyzed.
Veterans gained 1.4 kg per year (standard error [SE] = 0.47,
Findings from this study support the need for a long-term weight management program such as MOVE! in primary care settings to assist overweight and obese VA patients in achieving and maintaining weight loss to reduce the risk and progression of age-related chronic diseases such as diabetes and heart disease.
Obesity is associated with higher rates of hypertension, dyslipidemia, diabetes mellitus, degenerative joint disease, and coronary artery disease (
The prevalence of overweight and obesity in veterans is higher than in the general population but may be similar when the demographics of the veteran population are considered (
Adapting these research programs into ambulatory programs that can be feasibly delivered through the US Department of Veterans Affairs (VA) is challenging; the Veterans Health Administration (VHA) provides care to almost 6 million veterans through a nationwide network (
The purpose of this study was to determine significant predictors of weight loss at 3 years in veterans who attended the MOVE! multidisciplinary weight management program at the VA Greater Los Angeles Healthcare System (VAGLAHS). Findings from this study can provide evidence to support the need for a lifestyle modification program such as MOVE! in primary care settings to assist overweight and obese veterans in managing their weight.
This study was approved by the VAGLAHS institutional review board. All charts of veterans enrolled in MOVE! from April 1, 2006, to December 31, 2009, were reviewed. Veterans were referred to MOVE! by their primary care provider if they were obese (body mass index [BMI] >30 kg/m2) or overweight (BMI 25.0−29.9 kg/m2) and had comorbid conditions such as hypertension, hyperlipidemia, and type 2 diabetes.
The VA National Center for Health Promotion and Disease Prevention (NCP) developed MOVE! to provide a standardized format for weight management (
Typically, during the first encounter, staff provided an overview of the program and instructed veterans to complete a 23-item questionnaire on their diet, physical activity, health status, and prior weight loss attempts. An individualized report was then generated; it included a list of recommended print-ready materials on nutrition, physical activity, and healthy behavior changes available from the MOVE! website (
Pre-enrollment and postenrollment weight was obtained from veterans’ electronic medical records. Weight was measured and entered by the medical staff when the veteran attended his or her regularly scheduled medical appointment. Pre-enrollment weights consisted of measurements from 1 year before enrollment in the program, and postenrollment weight consisted of measurements available in the veteran’s medical record postenrollment in MOVE!. A 3-month window was used for pre-enrollment weights and at 1-, 2-, and 3-year follow-up, whereas a 1-month window was used at 3- and 6-month follow-up to increase the likelihood of obtaining a valid weight value from the medical record. Demographic characteristics, baseline weight, and comorbid conditions for the MOVE! participants were obtained, and all active medical diagnoses in patients’ medical records were included in the analysis.
Linear mixed-effects regression models with a piecewise linear function specified for each study participant (ie, participant-level random effects) were used to evaluate changes in body weight before and after enrollment in MOVE!. Covariates were age, sex, and linear piecewise-time segments (4 slopes: before MOVE!, and 0 to 1 year, >1 to 2 years, and >2 years post-MOVE!). The advantage of using a piecewise approach was that we could estimate the slopes simultaneously because we expected the time trends to be different for different time windows. The slopes before MOVE! versus 1 year post-MOVE! were estimated and compared through model contrasts. The model included participant-level random effects (ie, individual’s intercept and 4 slopes) to account for correlation among repeated observations among participants. For exploratory purposes, we conducted several subgroup analyses for the selected comorbid conditions using the same modeling approach as in the main analysis with the following additional terms in the model: condition (yes vs no) and condition-by-time interaction terms (1 for each time segment). All statistical analyses were conducted using SAS version 9.2 for Windows (SAS Institute, Inc, Cary, North Carolina).
A total of 382 veterans enrolled in the MOVE! program (
| Characteristic | Value |
|---|---|
|
| |
| Mean, y (SD) | 60 (11.1) |
| Median, y (range) | 62 (25–92) |
| No. missing (%) | 17 (4.5) |
|
| |
| Female | 30 (7.9) |
| Male | 335 (87.7) |
| Unknown/missing | 17 (4.5) |
|
| |
| Normal weight (<25) | 10 (2.6) |
| Overweight (≥25 and ≤29.9) | 63 (16.5) |
| Obese (≥30 and ≤39.9) | 233 (61.0) |
| Morbid obesity (≥40.0) | 76 (19.9) |
|
| |
| Mean (SD) | 110.1 (23.6) |
| Median | 106.4 |
| Range | 54.7–194.2 |
|
| |
| White | 53 (13.9) |
| Black | 48 (12.6) |
| Mexican American | 2 (0.5) |
| Unknown/missing | 279 (73.0) |
|
| |
| Hyperlipidemia | 276 (72.3) |
| Hypertension | 270 (70.7) |
| Mood disorder | 163 (42.7) |
| Type 2 diabetes | 152 (39.8) |
| Substance abuse | 126 (33.0) |
| Osteoarthritis | 103 (27.0) |
| Obstructive sleep apnea | 102 (26.7) |
| Posttraumatic stress disorder | 100 (26.2) |
| Gastroesophageal reflux disease | 75 (19.6) |
| Anxiety | 74 (19.4) |
| Coronary artery disease | 47 (12.3) |
| Schizophrenia | 36 (9.4) |
Study participants may have multiple comorbid conditions.
MOVE! participants who attended at least 3 sessions were included in the weight-change analysis (N = 377). Results from the mixed-effects piecewise regression model, adjusting for age and sex, indicated that veterans gained an average of 1.4 kg per year (standard error [SE] = 0.47,
| Parameter | Mean Weight Change, kg (Standard Error) |
|
|---|---|---|
|
| −0.27 (0.11) | .01 |
|
| 18.3 (4.31) | <.001 |
|
| ||
| Pre-MOVE! | 1.44 (0.47) | .003 |
|
| ||
| 0 to 1 year | −2.19 (0.42) | <.001 |
| >1 to 2 years | 0.95 (0.57) | .099 |
| >2 years | −0.54 (0.76) | .48 |
Analysis was adjusted for age at enrollment and sex.
Weight change pre- and postenrollment in the MOVE! Weight Management Program for Veterans, Los Angeles, California, 2006–2009.
Year Since MOVE! Start Weight, kg (95% Confidence Interval)
106 (103–109)
108 (105–110)
109 (107–112)
107 (104–109)
108 (105–110)
107 (105–110)
107 (104–111)
107 (103–112)
A significant weight loss (1.68 to 2.89 kg/y) was observed 1 year post-MOVE! among veterans who did not have comorbid conditions, except for those with hyperlipidemia or hypertension (
| Comorbid Condition | Without Condition, kg/y, Slope (SE) | With Condition, kg/y, Slope (SE) | ||
|---|---|---|---|---|
| Pre-MOVE! | 1 Year Post-MOVE! | Pre-MOVE! | 1 Year Post-MOVE! | |
| Osteoarthritis | 1.93 (0.58) | −2.20 (0.50) | 0.24 (0.86) | −1.67 (0.79) |
| Mood disorder | 1.18 (0.66) | −2.80 (0.57) | 1.64 (0.70) | −1.15 (0.63) |
| Coronary artery disease | 1.56 (0.52) | −2.31 (0.46) | 0.37 (1.30) | −1.53 (1.17) |
| Type 2 diabetes | 1.43 (0.63) | −2.07 (0.55) | 1.36 (0.75) | −2.02 (0.66) |
| Posttraumatic stress disorder | 1.13 (0.57) | −2.24 (0.50) | 2.07 (0.90) | −1.53 (0.82) |
| Substance abuse | 1.01 (0.59) | −2.42 (0.52) | 2.17 (0.83) | −1.32 (0.73) |
| Obstructive sleep apnea | 1.38 (0.57) | −1.76 (0.50) | 1.44 (0.90) | −2.79 (0.80) |
| Gastroesophageal reflux disease | 1.20 (0.55) | −1.68 (0.48) | 2.11 (1.03) | −3.47 (0.93) |
| Hyperlipidemia | 1.91 (1.01) | −0.54 (0.85) | 1.25 (0.55) | −2.54 (0.49) |
| Hypertension | 1.09 (0.99) | −0.54 (0.83) | 1.49 (0.55) | −2.57 (0.49) |
| Psychiatric diagnoses combined | 1.53 (0.64) | −2.89 (0.55) | 1.33 (0.71) | −1.25 (0.64) |
| ≥3 Comorbid conditions | 1.05 (1.15) | −2.05 (0.93) | 1.47 (0.53) | −2.05 (0.48) |
Abbreviation: SE, standard error.
All models were adjusted for age and sex.
Significant difference in pre-MOVE! and post-MOVE! slopes for veterans without comorbid condition was observed.
Significant difference in pre-MOVE! and post-MOVE! slopes for veterans with comorbid condition was observed.
We assessed treatment effects of MOVE! in a large sample of overweight and obese veterans by comparing the pre-MOVE! and post-MOVE! weight trajectory of veterans. Results indicated that veterans gained an average of 1.4 kg per year before enrolling in MOVE! and lost an average of 2.2 kg per year after enrolling in MOVE!; enrollment in MOVE! appeared to prevent further weight gain. Our results are consistent with those reported by Dahn et al (
Williamson and colleagues (
Multimorbidity was found in all age groups in this study. Major consequences of multimorbidity are disability and functional decline, poor quality of life, and high health care costs (
The prevalence of obesity among older adults has increased during the past 20 years and will affect both medical and social services. Along with an increased risk of cardiovascular disease, diabetes, and several cancers, obesity is associated with increased risk of physical and cognitive disability (
Our study has limitations. We evaluated the effectiveness of MOVE! as a large-scale, hospital-based program targeting overweight and obese veterans. Although the results might underestimate intervention effects, they provide a more realistic estimate of change given the actual clinical limitations affecting both veterans and treatment providers. Furthermore, the findings from this study support the implementation of a prevention-oriented health program that has been called for by VHA policy and clinical practice guidelines. The effects of the program should be further addressed by examining the implications of weight maintenance and weight reduction on health outcomes (including medication use and number of newly diagnosed cases of diabetes or cardiovascular disease) and health-care costs. Veterans receive care, including MOVE!, without cost, but they do not receive compensation for their participation in the program as participants in randomized control trials do. Future studies should examine the effect of monetary rewards on program participation, attrition, and weight loss maintenance.
A behavioral, multidisciplinary group weight-management program for veterans implemented at VAGLAHS was effective in achieving and maintaining weight loss over a 3-year period. Findings from this study support the need for a lifestyle modification program such as MOVE! in primary care settings to assist overweight and obese veterans in managing their weight over the long term and should include a maintenance program with monthly visits.
This research received no specific grant from any funding agency in the public, commercial, or nonprofit sectors.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions.